Aug 12, 2020

Public workspaceEnzyme-linked immunosorbent assay (ELISA) for detection of anti-HIV antibodies (ELISA) developed in various animal species. 

  • 1University of the West Indies St. Augustine
  • University of the West Indies
  • angel.vaillant@sta.uwi.edu
Icon indicating open access to content
QR code linking to this content
Protocol CitationAngel A Justiz-Vaillant 2020. Enzyme-linked immunosorbent assay (ELISA) for detection of anti-HIV antibodies (ELISA) developed in various animal species. . protocols.io https://dx.doi.org/10.17504/protocols.io.bjmzkk76
License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License,  which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Protocol status: Working
We use this protocol and it's working
Created: August 12, 2020
Last Modified: August 12, 2020
Protocol Integer ID: 40345
Disclaimer
DISCLAIMER – FOR INFORMATIONAL PURPOSES ONLY; USE AT YOUR OWN RISK

The protocol content here is for informational purposes only and does not constitute legal, medical, clinical, or safety advice, or otherwise; content added to protocols.io is not peer reviewed and may not have undergone a formal approval of any kind. Information presented in this protocol should not substitute for independent professional judgment, advice, diagnosis, or treatment. Any action you take or refrain from taking using or relying upon the information presented here is strictly at your own risk. You agree that neither the Company nor any of the authors, contributors, administrators, or anyone else associated with protocols.io, can be held responsible for your use of the information contained in or linked to this protocol or any of our Sites/Apps and Services.
Abstract
Enzyme-linked immunosorbent assay (ELISA) for studying the presence of anti-HIV antibodies in layer hens, rats and cats was a reproducible and feseable test. The presence of the anti-HIV antibodies was further confirmed by dot blot analysis.
Materials
MATERIALS
Reagent3,3′,5,5′-TetramethylbenzidineSigma AldrichCatalog #54827-17-7
ReagentELISA Diluent 2 x 120 mL Stemcell TechnologiesCatalog #1916
ReagentNunc™ 96-Well Polystyrene Round Bottom Microwell Plates, V 96 well plate, Non-Treated, clear, without lid, SterileThermo FisherCatalog #260210
ReagentELISA Blocker Blocking BufferThermo FisherCatalog #N502
ReagentCoating BufferBioLegendCatalog #421701
ReagentProtein LAG-anti-IgY-peroxidase (homemade)
Safety warnings
The risk associated with a particular microbe can be consulted in this website of the CDC (http://www.cdc.gov/biosafety/publications/BiologicalRiskAssessmentWorksheet.pdf)
The 96 well polystyrene microplates (U-shaped bottom) were coated with 50 ng of the synthetic gp-120 peptide in coating buffer overnight at 4°C.
The microplate is washed 4X (PBS-Tween-20) and blocked with 3% non-fat milk in PBS, 25 µl/well, 1h, RT.
The microplate is washed 4X (PBS-Tween-20) and triplicates of 25 µl of IgY (1 mg/ml), 25 µl of sera from cats or rats diluted 1:16 in PBS-non fat milk is added.
After incubation for 2 h at RT the microplate is washed 4X and 25 µl of a universal conjugate SpLAG-anti-IgY-HRP (comprised of peroxidase labelled-IgY chemically coupled to protein A, protein G and protein L) diluted 1:1000 was added and the plate incubated for a further 1 h at RT.
Then, the microplate is washed 4X and after that 3,3’,5,5’-tetramethylbenzidine (Sigma Chemical Co., St Louis, MO, USA) solution (50 µl) is added to each well.
After a further incubation of 15 min in the dark, the reaction is stopped when positive controls are coloured and blanks and negative controls do not.
Positive controls are from a positive human serum for anti-HIV antibodies, negative controls are from a turtle serum (Sigma Chemical Co., St Louis, MO, USA) and blanks 0.9% normal saline solution.
Cut-off point is calculated as the mean of negative controls multiplied by four.